Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (461-470 of 626) with videos related to

Pageof 63
Sort By:
Journal of Biomolecular Screening|June 18, 2009
Development and evaluation of a FACS-based medium-throughput assay for HCV entry inhibitorsSigrid Ziegler, Bernd Kronenberger, Beatrice A-M Albrecht, et al.
Journal of Medicinal Chemistry|October 14, 2005
Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosisMarieke Voets, Iris Antes, Christiane Scherer, et al.
Genes, Chromosomes & Cancer|May 17, 2024
Superficial fibromas with CTNNB1 mutationAnna Kuntze, R R Meliß, L Ermert, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylaseAngela Stefanachi, Nina Hanke, Leonardo Pisani, et al.
BMC Health Services Research|August 21, 2021
Organizational readiness to change as a leverage point for improving safety: a national nursing home surveyEmma D Quach, Lewis E Kazis, Shibei Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2,3 or 5-(alpha-azolylbenzyl)-1H-indolesM Le Borgne, P Marchand, B Delevoye-Seiller, et al.
European Journal of Medicinal Chemistry|December 6, 2017
Accelerated skin wound healing by selective 11β-Hydroxylase (CYP11B1) inhibitorsJuliette Emmerich, Chris J van Koppen, Jens L Burkhart, et al.
American Journal of Surgery|March 10, 2009
How does patient safety culture in the operating room and post-anesthesia care unit compare to the rest of the hospital?Haytham M A Kaafarani, Kamal M F Itani, Amy K Rosen, et al.
Journal of the American Medical Directors Association|July 24, 2020
Safety Climate Associated With Adverse Events in Nursing Homes: A National VA StudyEmma D Quach, Lewis E Kazis, Shibei Zhao, et al.
Journal of Medicinal Chemistry|February 24, 2011
Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyaseAngela Stefanachi, Angelo D Favia, Orazio Nicolotti, et al.
Pageof 63

Showing results (461-470 of 626) with videos related to

Sort By:
Pageof 63
Journal of Biomolecular Screening|June 18, 2009
Development and evaluation of a FACS-based medium-throughput assay for HCV entry inhibitorsSigrid Ziegler, Bernd Kronenberger, Beatrice A-M Albrecht, et al.
Journal of Medicinal Chemistry|October 14, 2005
Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosisMarieke Voets, Iris Antes, Christiane Scherer, et al.
Genes, Chromosomes & Cancer|May 17, 2024
Superficial fibromas with CTNNB1 mutationAnna Kuntze, R R Meliß, L Ermert, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylaseAngela Stefanachi, Nina Hanke, Leonardo Pisani, et al.
BMC Health Services Research|August 21, 2021
Organizational readiness to change as a leverage point for improving safety: a national nursing home surveyEmma D Quach, Lewis E Kazis, Shibei Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2,3 or 5-(alpha-azolylbenzyl)-1H-indolesM Le Borgne, P Marchand, B Delevoye-Seiller, et al.
European Journal of Medicinal Chemistry|December 6, 2017
Accelerated skin wound healing by selective 11β-Hydroxylase (CYP11B1) inhibitorsJuliette Emmerich, Chris J van Koppen, Jens L Burkhart, et al.
American Journal of Surgery|March 10, 2009
How does patient safety culture in the operating room and post-anesthesia care unit compare to the rest of the hospital?Haytham M A Kaafarani, Kamal M F Itani, Amy K Rosen, et al.
Journal of the American Medical Directors Association|July 24, 2020
Safety Climate Associated With Adverse Events in Nursing Homes: A National VA StudyEmma D Quach, Lewis E Kazis, Shibei Zhao, et al.
Journal of Medicinal Chemistry|February 24, 2011
Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyaseAngela Stefanachi, Angelo D Favia, Orazio Nicolotti, et al.
Pageof 63